Most cases are mild, resolve within minutes to hours, and do not require treatment discontinuation
In 2024, a Harvard study found that the drugs were also linked to an increased risk of sudden and irreversible vision loss and blindness
These medications should only be used when clinically indicated and under the guidance of a qualified healthcare professional
Common symptoms Fewer than three bowel movements per week Hard, dry, or lumpy stools Straining during bowel movements Sensation of incomplete emptying of bowels Abdominal discomfort, bloating, or cramping Feeling of fullness or pressure in the rectum Possible nausea or reduced appetite How common is constipation with GLP-1 treatments
And even after a patent expires, it can still take time for a generic to become available
For broader receptor profiles such as the triple agonist retatrutide, the glucagon-mediated component is an additional research parameter whose tolerability contribution continues to be investigated in the Phase 2 data